Trial Site Detail

 

Drug:
Olaratumab (IMC-3G3)
Trial:
A Study of IMC-3G3 in Previously Treated Patients With Unresectable and/or Metastatic Gastrointestinal Stromal Tumors
Conditions: Gastrointestinal Stromal Tumor
Trial Status:
Terminated

 

Masonic Cancer Center at University of Minnesota

     
Minneapolis , MN 55455
USA

 

Principal Investigator:
Contact:
Activation Status of this Site:
Closed
Notes about this Site:
Masonic Cancer Center at University of Minnesota Website:
http://www.cancer.umn.edu/research/clinicaltrials/index.php

 

 

Navigating the Map

Use the plus (+) and minus (-) controls to zoom in/out.

Click and drag the map or use the arrows to move (pan) the map.

Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.